Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;89:818-826

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagatsu, M.
Right arrow Articles by Carabello, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagatsu, M.
Right arrow Articles by Carabello, B. A.

Circulation, Vol 89, 818-826, Copyright © 1994 by American Heart Association


ARTICLES

Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function

M Nagatsu, MR Zile, H Tsutsui, PG Schmid, G DeFreyte, G Cooper 4th and BA Carabello
Department of Medicine, Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston 29425-2221.

BACKGROUND: It is generally accepted that the adrenergic nervous system provides inotropic support for the failing heart. However, the magnitude of this support has never been studied extensively. The present study was performed to test the hypothesis that the adrenergic nervous system is capable of maintaining indexes of pump and contractile function in the normal range despite significant innate myocardial depression. METHODS AND RESULTS: We used our model of experimental canine mitral regurgitation, which produces left ventricular dysfunction after 3 months of volume overload. We studied indexes of contractile function on and off beta-blockade at baseline and again on and off beta-blockade 3 months after chronic mitral regurgitation had induced significant contractile dysfunction. At baseline, acute beta-blockade caused insignificant reductions in the mass-corrected slope of the end-ejection stress-volume relation (EESVR), the end-systolic stiffness constant, and the ejection fraction- end-systolic stress and the mean velocity of circumferential fiber shortening (VCF)-end-systolic stress relations. After 3 months of chronic mitral regurgitation, all indexes of contractile function were normal in the unblocked state except for the VCF-stress relation, which was mildly reduced. However, after acute beta-blockade after 3 months of chronic mitral regurgitation, the EESVR fell to 303 +/- 27 versus 443 +/- 24 during acute beta-blockade before mitral regurgitation was created (P < .05), and the end-systolic stiffness constant was reduced to 2.54 +/- 0.15 versus 3.27 +/- 0.11 (P < .05). Only after beta- blockade was the ejection fraction-stress relation significantly reduced for dogs with chronic mitral regurgitation. The VCF-stress relation became markedly more abnormal. The viscosity-velocity relation of myocytes isolated from the ventricles of the dogs with mitral regurgitation confirmed that substantial innate contractile depression was present. CONCLUSIONS: After 3 months of chronic mitral regurgitation, the adrenergic nervous system was able to maintain most indexes of contractile function in the normal range despite significant depression in innate contractile function. Thus, in the absence of beta- blockade, significant innate contractile depression may be obscured by adrenergic support.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. H. Hankes, J. L. Ardell, J. Tallaj, C.-C. Wei, I. Aban, M. Holland, P. Rynders, R. Dillon, R. Cardinal, D. B. Hoover, et al.
beta1-Adrenoceptor blockade mitigates excessive norepinephrine release into cardiac interstitium in mitral regurgitation in dog
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H147 - H151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Nemoto, P. Razeghi, M. Ishiyama, G. De Freitas, H. Taegtmeyer, and B. A. Carabello
PPAR-{gamma} agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H77 - H82.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Byrne, D. M. Kaye, M. Mathis, D. G. Reuter, C. A. Alferness, and J. M. Power
Percutaneous Mitral Annular Reduction Provides Continued Benefit in an Ovine Model of Dilated Cardiomyopathy
Circulation, November 9, 2004; 110(19): 3088 - 3092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. M. Grossman, O. A. Linares, M. A. Supiano, H. Oral, R. H. Mehta, and M. R. Starling
Cardiac-specific norepinephrine mass transport and its relationship to left ventricular size and systolic performance
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H878 - H888.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. A. Carabello
Is it ever too late to operate on the patient with valvular heart disease?
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Nemoto, M. Hamawaki, G. De Freitas, and B. A. Carabello
differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 149 - 154.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. J. Perry, C.-C. Wei, G. H. Hankes, S. R. Dillon, P. Rynders, R. Mukherjee, F. G. Spinale, and L. J. Dell'Italia
Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog
J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1374 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Senzaki, C.-H. Chen, S. Masutani, M. Taketazu, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, and Y. Yokote
Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease
J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 535 - 547.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Nagatsu, F. G. Spinale, M. Koide, H. Tagawa, G. DeFreitas, G. Cooper IV, and B. A. Carabello
Bradycardia and the Role of {beta}-Blockade in the Amelioration of Left Ventricular Dysfunction
Circulation, February 15, 2000; 101(6): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Hasenfuss
Animal models of human cardiovascular disease, heart failure and hypertrophy
Cardiovasc Res, July 1, 1998; 39(1): 60 - 76.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. G. Spinale, M. L. Coker, C. V. Thomas, J. D. Walker, R. Mukherjee, and L. Hebbar
Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure : Relation to Ventricular and Myocyte Function
Circ. Res., March 9, 1998; 82(4): 482 - 495.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Zhang, C. Toher, M. Erhard, Y. Zhang, K. Ugurbil, R. J. Bache, T. Lange, and D. C. Homans
Relationships Between Myocardial Bioenergetic and Left Ventricular Function in Hearts With Volume-Overload Hypertrophy
Circulation, July 1, 1997; 96(1): 334 - 343.
[Abstract] [Full Text]